For decades, the geography of international drug trafficking was closely tied to the location of particular crops. Coca cultivation made Colombia, Peru, and Bolivia strategically important to global cocaine production, while opium poppy cultivation gave regions such as Afghanistan and Myanmar a similar role in the opiate trade. Extensive networks of processing, transportation, and distribution developed around these territories, with major criminal organizations gaining control over critical segments of the business.
The expansion of synthetic drugs is changing some of the conditions that sustained this system. Substances such as methamphetamine and fentanyl can be manufactured without agricultural crops, through chemical processes whose location depends on different factors. Access to industrial chemicals, technical expertise, and commercial networks is becoming increasingly important, while production can take place in territories that previously played a secondary role in the geography of drug trafficking.
It also changes the job of governments. Chemicals used in synthetic drug manufacturing can move legally through international trade before being diverted to clandestine facilities. Others are subject to specific controls, making their movement and diversion a different regulatory challenge. At the same time, the possibility of producing certain substances in relatively small laboratories creates opportunities for local manufacturers to operate with greater independence from major transnational criminal organizations. If the fragmentation becomes widespread, law enforcement agencies face more dispersed networks that are harder to investigate.
Manufacturing can spread across new territories and potentially involve more participants, but large criminal organizations retain significant advantages in chemical procurement, industrial-scale production, and market access. Production could disperse even as profits concentrate.
From Agricultural Territory to Industrial Supply Chains
Cocaine production is constrained by a relatively limited agricultural geography. Although processing facilities and trafficking routes can shift, coca cultivation remains concentrated primarily in the Andean region.
This territorial dependence helped shape the historical distribution of criminal power. During the 1980s and 1990s, Colombian organizations such as the Medellín and Cali cartels controlled crucial segments of the international cocaine trade. Mexican criminal organizations subsequently gained a dominant position in transportation and distribution toward the United States.
Synthetic drugs allow for a different production model. Manufacturing can take place in various territories wherever the necessary chemicals, technical expertise, infrastructure, and conditions for clandestine operations exist. The origin of chemical inputs, the location of manufacturing, and the consumer market may all be situated in different countries.
This flexibility creates new economic possibilities. Smaller producers may benefit from proximity to consumers, while larger organizations can reduce costs through industrial-scale operations, bulk purchasing, and established distribution networks.
Being able to make a drug in many places does not decide who controls its supply. Competition also depends on financing, access to chemicals, and the ability to maintain consistent production and distribution.
China, India, and Emerging Production Centers
The growth of synthetic drugs has increased the importance of chemical and pharmaceutical industries within certain international supply chains.
China and India have become significant sources of chemicals or finished synthetic substances in particular markets, while large-scale illicit manufacturing has taken root in Mexico and Myanmar.
This international division of functions is especially visible in the US fentanyl market. According to a 2025 report by the US Government Accountability Office (GAO), approximately 84 percent of fentanyl precursor chemicals seized by Department of Homeland Security agencies during fiscal years 2021–2024 came from China, while around 68 percent of seized finished fentanyl came from Mexico.
These figures describe the reported origins of seized substances, not verified shares of the global illicit market. Still, they show how a single production chain can connect chemical suppliers, clandestine manufacturers, and consumers in different countries.
Europe presents another configuration. The European Union Drugs Agency (EUDA) reported that quantities of synthetic cathinones recorded in major imports and seizures reached approximately 37 tonnes in 2023, compared with 4.5 tonnes in 2021. A significant share involved consignments originating in India, entering Europe primarily through the Netherlands.
In Southeast Asia, Myanmar represents a different model. Illicit methamphetamine manufacturing has expanded particularly in Shan State, where armed conflict, fragmented authority, and established criminal networks have helped sustain clandestine production centers. These dynamics are examined in UNODC’s 2025 report, Synthetic Drugs in East and Southeast Asia.
The importance of these countries must be interpreted carefully. China’s and India’s chemical industries primarily serve legitimate economic activities, and the origin of a chemical does not demonstrate deliberate involvement by its manufacturers or governments in drug trafficking.
Nor does supplying chemical inputs necessarily imply control over the business. Organizations that dominate manufacturing, transportation, and distribution may capture a far greater share of illicit profits than the original suppliers.
What is emerging is a division of labor among legitimate industries, clandestine production centers, and criminal networks controlling different segments of the supply chain.
Small Laboratories and the Concentration of Criminal Power
If synthetic drugs can be made in small facilities, can independent producers compete with the major cartels?
In Czechia, clandestine methamphetamine manufacturing has a long history associated with small laboratories, often supplying local markets. According to the EUDA’s European Drug Report 2026, Czech authorities dismantled 184 methamphetamine laboratories in 2024.
In the Netherlands, larger industrial-scale facilities have been identified in connection with networks supplying international markets. Dutch authorities dismantled 23 methamphetamine laboratories during the same year.
The numerical difference does not establish which country produces larger quantities. A single industrial facility may have considerably greater output than numerous small laboratories, while dismantling figures also reflect law enforcement activity.
Still, the contrast points to two models: relatively dispersed production for local markets coexists with manufacturing organized around industrial facilities and broader commercial networks.
For years, part of the methamphetamine consumed in the United States was manufactured in numerous small clandestine laboratories. Over time, the market became increasingly dependent on criminal organizations producing methamphetamine in Mexico.
According to the DEA’s 2024 National Drug Threat Assessment, domestic methamphetamine laboratory seizures declined from approximately 23,700 in 2004 to just 60 in 2023. The agency’s 2025 National Drug Threat Assessment continues to identify Mexican criminal organizations as the principal suppliers to the US methamphetamine market.
Precursor restrictions, law enforcement operations, and the economic advantages of industrial production contributed to this transformation. Being able to make the drug at home did not keep small US producers in business once Mexican networks could supply the market at scale.
More laboratories need not mean power spread across more hands.
There is also a fundamental distinction between the number of laboratories and the number of criminal organizations. Several facilities may belong to the same network, while seemingly independent manufacturers may rely on major intermediaries for chemical supplies or access to consumers. More laboratories, in short, need not mean power spread across more hands.
The evidence shows both models at work. It does not yet show whether synthetic drug markets are becoming more economically decentralized.
From Borders to Laboratories: A New Challenge for Law Enforcement
The transformation of production chains is also changing the conditions under which governments attempt to combat drug trafficking.
In the international cocaine trade, customs authorities seek to detect shipments of an illicit substance crossing national borders, often concealed among legitimate goods. In certain synthetic drug supply chains, however, some chemical inputs can enter through lawful commercial transactions before being diverted to clandestine manufacturing.
This creates a particular difficulty: a chemical may have legitimate industrial applications and circulate legally through international trade, while its criminal use emerges at a later stage. Other substances are already subject to controls, and their importation or diversion may itself constitute an offense.
The problem has precedents in cocaine and heroin production, which also require chemicals obtained from legitimate markets. However, it becomes especially significant when a drug can be manufactured entirely through chemical processes, potentially within the consumer country itself.
Border controls therefore need backing from commercial supply-chain monitoring, the identification of intermediaries, and investigations into possible diversion toward clandestine facilities.
Regulation faces an additional challenge: criminal organizations may attempt to replace controlled substances with alternative compounds or change suppliers.
China introduced class-wide controls on fentanyl-related substances in May 2019, as documented by UNODC. However, controlling finished drugs and regulating the chemicals used in their manufacture require different instruments.
Fragmented manufacturing would add another problem. Investigations targeting major transnational criminal organizations often focus on trafficking routes, intermediaries, financial structures, and distribution networks. If numerous independent local manufacturers emerge, law enforcement agencies could face smaller and more dispersed units with less obvious connections to one another.
That would mean combining international investigations with local criminal intelligence, commercial transaction monitoring, and cooperation among customs, police, and financial authorities.
Nor would every laboratory be independent: a single criminal structure may operate several facilities or rely on manufacturers with varying degrees of autonomy.
Law enforcement also has to work out whether apparent fragmentation represents a genuine redistribution of criminal power or an operational reorganization of existing networks.
Local manufacturing may create new opportunities for detection, but it also requires authorities to investigate activities that cannot always be identified through the interception of international shipments of finished drugs.
The effectiveness of state control will increasingly depend on the ability to trace both legitimate supply chains vulnerable to diversion and the clandestine structures that transform and distribute their chemical inputs.
The Future of Traditional Producing Territories
The growth of these markets does not demonstrate that cocaine is being displaced globally.
According to the UNODC World Drug Report 2026, estimated potential illicit cocaine manufacture reached approximately 4,100 tonnes in 2024, with an estimated range of 3,800–4,700 tonnes. This is the highest figure in UNODC’s 2010–2024 series.
Nor are the drugs substitutes for one another. Fentanyl is an opioid, while cocaine and methamphetamine are stimulants with different characteristics and patterns of consumption.
It is too early to write off Colombia, Peru, and Bolivia because synthetic drugs are spreading.
One possibility is that the global cocaine market will continue to grow while other supply chains acquire greater relative importance within an increasingly diversified illicit economy.
In that case, the old growing regions would keep their relevance while sharing strategic importance with industrial regions, clandestine manufacturing centers, and new commercial routes.
The new geography is being layered onto the old one.
The Changing Geography of Criminal Power
The expansion of synthetic drugs is changing the resources and capabilities required to participate in international drug trafficking.
Control over agricultural territories remains decisive for certain substances, but access to chemical inputs, industrial capacity, and distribution networks is becoming more important in other markets.
For governments, the fight moves from the border into the supply chain. The possibility that some chemical inputs may circulate legally before being diverted into clandestine manufacturing requires surveillance beyond the border. A potential proliferation of independent producers could also alter traditional criminal investigation strategies.
Yet the available evidence shows that greater manufacturing flexibility can coexist with concentrated economic structures. Counting laboratories does not count their owners, and a local lab may still depend on a cartel for its chemicals and its buyers.
The real question is who controls the resources that turn that flexibility into economic power.
Synthetic drugs are changing where illicit substances can be manufactured and how production can be organized. Whether they are also redistributing criminal power, or creating new mechanisms for concentrating it, is not yet clear.